Biodistribution, shedding, and transmissibility of the oncolytic virus talimogene laherparepvec in patients with melanoma

BACKGROUND: Talimogene laherparepvec (T-VEC) is an intralesionally delivered, modified herpes simplex virus type-1 oncolytic immunotherapy. The biodistribution, shedding, and potential transmission of T-VEC was systematically evaluated during and after completion of therapy in adults with advanced m...

Descripción completa

Detalles Bibliográficos
Autores principales: Andtbacka, Robert H.I., Amatruda, Thomas, Nemunaitis, John, Zager, Jonathan S., Walker, John, Chesney, Jason A., Liu, Kate, Hsu, Cheng-Pang, Pickett, Cheryl A., Mehnert, Janice M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2019
Materias:
Research paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6796514/
https://www.ncbi.nlm.nih.gov/pubmed/31409575
http://dx.doi.org/10.1016/j.ebiom.2019.07.066

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6796514/
https://www.ncbi.nlm.nih.gov/pubmed/31409575
http://dx.doi.org/10.1016/j.ebiom.2019.07.066

Ejemplares similares